tiprankstipranks
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
PremiumPress ReleasesAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
2M ago
Achilles Therapeutics: Promising Q1 2024 Results
PremiumCompany Announcements
Achilles Therapeutics: Promising Q1 2024 Results
2M ago
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
2M ago
Achilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
PremiumThe FlyAchilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
3M ago
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
3M ago
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
PremiumThe Fly
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
3M ago
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
PremiumPress ReleasesAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
7M ago
Achilles Therapeutics just downgraded at BofA, here’s why
PremiumThe Fly
Achilles Therapeutics just downgraded at BofA, here’s why
7M ago
Achilles Therapeutics reports Q3 EPS (42c), consensus (40c)
PremiumThe Fly
Achilles Therapeutics reports Q3 EPS (42c), consensus (40c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100